Clinigence Holdings Inc ( (NUTX) ) has released its Q1 earnings. Here is a breakdown of the information Clinigence Holdings Inc presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nutex Health Inc., a physician-led healthcare delivery system, operates micro-hospitals and hospital outpatient departments across 11 states, focusing on integrated healthcare services.
In the first quarter of 2025, Nutex Health reported a substantial increase in financial performance, with total revenue reaching $211.8 million, a 213.8% rise from the previous year, and a net income of $14.6 million compared to a net loss in the same period of 2024.
Key financial metrics showed significant improvements, including an EBITDA increase of 507% to $43.1 million and an adjusted EBITDA of $72.8 million. The company also reported a record high net cash from operating activities of $51 million and a gross profit margin of 56%. The arbitration process contributed significantly to revenue growth, adding approximately $105 million.
Nutex Health’s management expressed optimism about the company’s financial trajectory, highlighting operational efficiencies and volume growth as key drivers. The company plans to continue optimizing operations and maintaining a lean cost structure to support sustained growth.
Looking forward, Nutex Health aims to build on its positive momentum, focusing on consistent financial results and operational efficiency to drive future growth, while acknowledging the challenges ahead.